Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Chugai presents new highly potent and selective AXL inhibitor

Aug. 27, 2012

Folate-rapamycin conjugate shows promise to treat PKD

Aug. 23, 2012

New TRPM8 channel antagonists disclosed by Dompe Farmaceutici

Aug. 23, 2012

Collaboration yields novel prostanoid EP1 receptor antagonists

Aug. 21, 2012

New sildenafil formulation launched in Korea to treat erectile dysfunction

Aug. 21, 2012

Roche reports novel bradykinin B1 receptor antagonists

Aug. 17, 2012

Nymox reports on long-term follow-up studies of NX-1207

Aug. 2, 2012

Japanese researchers disclose new xanthine oxidase inhibitors

Aug. 2, 2012

Otsuka seeks approval for additional indication of Samsca

Aug. 2, 2012

La Jolla Pharmaceutical gives update on GCS-100 plans

Aug. 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...